A New Clean Hydrogen Option: Make It Underground

This week’s Current Climate newsletter also looks at tough market conditions for Tesla’s Semi and how offshore wind farms can stabilize New England’s electricity grid.

Conditions At ICE Detention Centers Could Fuel Major Measles Outbreaks

In this week’s edition of InnovationRx, we look at we look at Reed Jobs’ cancer-focused VC fund, Midi Health’s latest fundraise at $1 billion-plus valuation, and more.

Tesla Suddenly Likes Solar Again

This week’s Current Climate newsletter also looks at Indiana’s plan to get rare earths from coal waste and how batteries keep power flowing in Texas

Medium gives employees Friday off to participate in national strike protesting ICE

Activists behind the general strike are calling for “no work, no school, and no shopping” amid a push to defund ICE, which has escalated raids in U.S. cities, killing several people, including two U.S. citizens earlier this month in Minneapolis.

That Green ‘Scam’ Is The Top Source Of New U.S. Electricity

This week’s Current Climate newsletter also looks at aiding the power crunch with more efficient buildings and using fuel cells to help curb data center pollution

WHO Calls Trump Administration Reasons For U.S. Withdrawal ‘Untrue’

The World Health Organization Director General stated that a post by Robert F. Kennedy, Jr., on X about the U.S. withdrawal from the WHO contains inaccurate information

Apps for boycotting American products surge to the top of the Danish App Store

Two origin ID apps, NonUSA and Made O’Meter, are seeing downloads surge as Europeans boycott US-made goods.

The Short-Sighted, $27 Billion U.S. EV Retreat

This week’s Current Climate newsletter also looks at Brightline’s rising bullet train costs and how Ecolab is solving the data center water problem.

The U.S. Goes Rogue On The Climate Fight

This week’s Current Climate newsletter also looks at the AI boom’s water problem and stabilized funding for the California High-Speed Rail project.

Measles And Flu Hit New Highs As Trump Administration Hammers Vaccines

In this week’s edition of InnovationRx, we look at a former Wall Street analyst’s $4 billion obesity drug company, Wegovy’s weight-loss pill, and more.